Clinical Trials for Worldwide Clinical Trials

A Study Investigating Coagadex in the Treatment AFXD Associated With AL Amyloidosis

GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder With Comorbid Anxiety and Insomnia

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

CRF2 Agonist for the Treatment of Worsening Heart Failure

Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)

A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.

GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder

Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy

"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"

Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy

A Study of a N, N-dimethyltryptamine (DMT) Analog (CYB004) in Participants with Generalized Anxiety Disorder (GAD)

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

An Open-label Study of XEN1101 in Epilepsy

A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures

A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)

Evaluating the Efficacy and Safety of Nilotinib BE in Subjects With Early Alzheimer's Disease

A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme

Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients

NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's Disease or Lewy Body Dementia (Cognition, Memory, Attention, Thinking)